Vol 13, No 1 (2019)
Case report
Published online: 2019-04-04
Pharmacological treatment of hemoptysis in a patient diagnosed with lung tumor and chronic atrial fibrillation
Palliat Med Pract 2019;13(1):35-38.
Abstract
W artykule przedstawiono skuteczne i dobrze tolerowane leczenie farmakologiczne krwioplucia u 95-letniego pacjenta z rozpoznaniem guza płuca. W pracy omówiono wyzwania terapii związane z wielochorobowością i inne możliwości leczenia krwioplucia. Palliat Med Pract 2019; 13, 1: 35–38
Keywords: kwas traneksamowyetamsylatkrwioplucieguz płuc
References
- Garay RP, Chiavaroli C, Hannaert P. Therapeutic efficacy and mechanism of action of ethamsylate, a long-standing hemostatic agent. Am J Ther. 2006; 13(3): 236–247.
- Ittrich H, Bockhorn M, Klose H, et al. The Diagnosis and Treatment of Hemoptysis. Dtsch Arztebl Int. 2017; 114(21): 371–381.
- Lip , et al. See Van den Ham et al.CHADSVASC clinical risk estimation.
- Hamilton W, Peters TJ, Round A, et al. What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study. Thorax. 2005; 60(12): 1059–1065.
- Hu P, Wang G, Cao H, et al. Haemoptysis as a prognostic factor in lung adenocarcinoma after curative resection. Br J Cancer. 2013; 109(6): 1609–1617.
- Hulme B, Wilcox S. Yorkshire Palliative Medicine Clinical Guidelines Group Guidelines on the management of bleeding for palliative care patients with cancer, November 2008.
- Sakr L, Dutau H. Massive hemoptysis: an update on the role of bronchoscopy in diagnosis and management. Respiration. 2010; 80(1): 38–58.
- Charakterystyka Produktu Leczniczego, Cyclonamine.
- Lewis GJ. Does ethamsylate increase the incidence of venous thrombosis? Br Med J (Clin Res Ed). 1984; 288(6421): 899–900.
- Symes DM, Offen DN, Lyttle JA, et al. The effect of dicynene on blood loss during and after transurethral resection of the prostate. Br J Urol. 1975; 47(2): 203–207.
- Gadre A, Stoller J. Tranexamic Acid for Hemoptysis. Clinical Pulmonary Medicine. 2017; 24(2): 69–74.
- Prutsky G, Domecq JP, Salazar CA, et al. Antifibrinolytic therapy to reduce haemoptysis from any cause. Cochrane Database Syst Rev. 2016; 11: CD008711.
- Calapai G. Systematic Review of Tranexamic Acid Adverse Reactions. Journal of Pharmacovigilance. 2015; 03(04).
- Gagnon S, Quigley N, Dutau H, et al. Approach to Hemoptysis in the Modern Era. Can Respir J. 2017; 2017: 1565030.
